Aurobindo Pharma receives approvals
Aurobindo Pharma has announced that its tentatively approved ANDAs for Nevirapine Tablets 200 mg (ANDA 077521) and Nevirapine Oral…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Quintiles releases New Health Report 2012
Biopharmaceutical services company Quintiles has commissioned New Health Report 2012. Now in its third year, The New Health Report…
Present pharma pricing policy will hurt both patients and industry in the long run: Experts
Suitable alternative required to balance the need for low drug prices, sustained innovation and access to affordable healthcare…
IHP, PFCD concludes expert panel discussion on NCDs
India Health Progress (IHP) and Partnership to Fight Chronic Disease (PFCD) has hosted a panel discussion in Chennai on…
Piramal Healthcare to present phase I data for oral anticancer molecule at ASCO
Piramal Healthcare announced that phase I clinical trial data for its investigational new drug candidate P1446A-05 will be…
Venus Remedies bags patent grant from SA
Venus Remedies has received its first patent for a novel antibiotic combination of carbapenem and aminoglycoside. Pioneering into…
Health ministers to debate binding convention on R&D
MSF urges the ministers at the 65th World Health Assembly to seize this unique opportunity The world’s health ministers, gathering…
DBT calls for proposals on low cost health care technologies, products
Diagnostics for infectious disease and allergy, biomedical devices and vaccines are key focus areas; submissions close on June 30,…
US FDA gives approval for generic version of Plavix
The US FDA has approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate). The companies which have…
Ind-Swift with Wockhardt UK launches atorvastatin tabs in UK
Ind-Swift Laboratories has launched generic formulations of atorvastatin in the UK in collaboration with Wockhardt UK on the first…